Live from the NIH registry
Studies recruiting near Eugene right now
Top 25 of 147 recruiting studies, sorted by proximity — each links to its official registry page
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
Child Abuse, Decision Making
N/A
Interventional 80 participants sought
Chestnut Health Systems — Eugene, Oregon (1.6 mi)
· Sponsor: Chestnut Health Systems
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Oncology Associates of Oregon (Willamette Valley Cancer Institute and Research Center) — Eugene, Oregon (1.6 mi)
· Sponsor: SCRI Development Innovations, LLC
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Oncology Associates of Oregon PC — Eugene, Oregon (1.6 mi)
· Sponsor: Revolution Medicines, Inc.
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Essential Thrombocythemia
Phase 3
Interventional 426 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi)
· Sponsor: Incyte Corporation
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
517 — Eugene, Oregon (1.6 mi)
· Sponsor: Corcept Therapeutics
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Metastatic Castration-resistant Prostatic Neoplasms
Phase 3
Interventional 1,203 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi)
· Sponsor: Janssen Research & Development, LLC
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Keratoconus, Unstable, Bacterial Keratitis
Phase 1
Interventional 300 participants sought
Pacific Clear Vision Institute — Eugene, Oregon (1.6 mi)
· Sponsor: Pacific Clear Vision Institute
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Chronic Low-back Pain, Vertebrogenic Pain Syndrome
N/A
Observational 1,500 participants sought
Pacific Sports and Spine — Eugene, Oregon (1.6 mi)
· Sponsor: Boston Scientific Corporation
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Oncology Associates of Oregon, P.C. — Eugene, Oregon (1.6 mi)
· Sponsor: Pfizer
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi)
· Sponsor: US Oncology Research
Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles
Muscle Tone, Muscle Strength
N/A
Interventional 44 participants sought
Movassaghi Plastic Surgery & Ziba Medical Spa — Eugene, Oregon (1.6 mi)
· Sponsor: Sofwave Medical LTD
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Genetic Disease
N/A
Observational 20,000 participants sought
University of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: National Human Genome Research Institute (NHGRI)
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 3
Interventional 531 participants sought
Willamette Valley Cancer Institute and Research Center /ID# 280617 — Eugene, Oregon (1.6 mi)
· Sponsor: AbbVie
Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
Overweight or Obesity
N/A
Interventional 120 participants sought
Oregon Research Institute Community and Evaluation Services — Springfield, Oregon (4.8 mi)
· Sponsor: ORI Community and Evaluation Services
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 630 participants sought
Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon (1.6 mi)
· Sponsor: BeOne Medicines
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
B-cell Lymphoma, Chronic Lymphocytic Leukemia
Phase 1, Phase 2
Interventional 150 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Endometrial Cancer, Malignant Solid Tumour
Phase 3
Interventional 800 participants sought
Research Site — Eugene, Oregon (1.6 mi)
· Sponsor: AstraZeneca
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi)
· Sponsor: Novartis Pharmaceuticals
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi)
· Sponsor: Urotronic Inc.
Garden-fresh Foods and Gut Microbiomes
Gut Microbiome
N/A
Interventional 20 participants sought
Institute for Health in the Built Environment, University of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: University of Oregon
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Oncology Associates of Oregon, P.C. /ID# 275006 — Eugene, Oregon (1.6 mi)
· Sponsor: AbbVie
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Multiple Myeloma
Phase 2
Interventional 100 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
USOR Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
CLL, Chronic Lymphocytic Leukemia
Phase 3
Interventional 250 participants sought
Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon (1.6 mi)
· Sponsor: BeOne Medicines